July 27, 2016
The Society of Nuclear Medicine and Molecular Imaging recently presented at a high-level stakeholders meeting at the Nuclear Regulatory Commission. The NRC Chairman and Commissioners met with numerous stakeholders to discuss matters such as the efficiency and effectiveness of NRC regulatory programs, effectiveness of public engagement, and the use of risk insights in regulations and decision-making. Participants included Fred Fahey, DSc, FSNMMI, FACR, FAAPM, (representing SNMMI), states, public interest groups, nuclear power plant operators, new reactor vendors, and former NRC Commissioners.
Dr. Fahey represented the society and provided the medical perspective for NRC. Dr. Fahey's presentation highlighted the impact of radioactive materials on patients, NRC's impact on patients, inspections, resolution of stakeholder comments and regulatory analysis, as well as communication between the NRC and the medical community. SNMMI continues to see ways to engage with regulators and communicate the value of nuclear medicine and molecular imaging.